Migraine and Emesis Flashcards

1
Q

What is a migraine? (14:42)

A
  • Painful, pulsing headache typically lasting 4 hours to 3 days
  • Often unilateral, associated with photophobia
  • 7% of men and 17% of women experience at least one migraine a year
  • Prevalence peaks in middle age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the incidence of migraine.

A
  • Episodic
  • 10 to 15% of population
  • Female:Male ratio 3.5:1
  • Affects 16% of menstruating females
  • 2-3 times more common if first degree relative has it
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the cost of migraine?

A
  • 100,000 absent from work or school as a result every day
  • Costing UK economy £1.5 billion per annum
  • No effect on life expectancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the symptomology of migraine.

A

Up to five stages:

Prodrome:
- Yawning, mood or appetite change (warning phase, occurs in 60%)

1) Aura (Classical Migraine):
- Initial visual disturbance, 30 minutes
- Visual area lost, surrounding area ‘shimmers’
- 15% of sufferers = Classical Migraine (w/aura) + Unilateral…

2) Unilateral throbbing headache (Common Migraine):
- Lasting 4 to 72 hours
- Photophobia
- N&V
- Prostrate; to lie down
- 85% of sufferers = Common Migraine, going straight into this phase (no aura)

Resolution:
- Deep sleep and loss of headache

Recovery:
- Often get exhausation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the genetic risks of migraine? What are the mutations?

A

Familial hemiplegic migraine; w/aura:

  • Rare autosomal disorder
  • 50% of cases; point mutations in CACNA1A gene; encodes pore-forming α1A subunit of the P/Q voltage-gated calcium channel (chromosome 19)
  • Mutations result in an altered channel conductance and density of expression in vitro in cell lines
  • 30% of cases; mutations in the ATP1A2 gene that encodes the Na+k+ pump α2 subunit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What mutation is associated with Common Migraine?

A
  • Mutation in the TRESK K2P potassium channel in spinal neurones
  • Common Migraine; w/o aura (85%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the pathophysiology of migraines WRT it being of vascular origin (now disproven)?

A

Was thought to be as a result of abnormal cerebral blood flow:
- Intracerebral vasoconstriction was thought to cause the aura (Classical Migraine)
- Extracerebral vasodilation (particularly in dura mater)
»> Resulting in pain

• However, blood flow changes do not occur in Common Migraine (sans aura)
• MRI cerebral blood flow analysis confirmed biphasic changes, but wrong pattern.
»> Headache started in vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the pathophysiology of migraines WRT the cortical spreading depression theory; neuronal origin (kinda right/kinda disproven)

A
  • Blood flow change does not correspond to intracranial artery distribution
  • Vasoconstriction spreads from posterior of one hemisphere = neural mediation (depression of cortical neurones in animals)
  • May be cause of aura, but not migraine.
  • Changes in blood flow driven by change in metabolic demand resulting from neuronal depression are thought to result in progressive change in MR signal in occipital cortex
  • Aura usually involves wave of electrical activity starting in the occipital cortex, spreading slowly at 2-3 mm/min associated w/visual hallucinations across the visual field, that are reproducible in the same individual
  • Therapy that prevents the aura can still leave the headache
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain the pathophysiology of migraines WRT the current theory; sensory nerve activation is the cause. What is released/responsible?

A

Migraine = enhanced trigeminovascular neuron activity
- Trigeminal nerve innervates frontal and parietal cortex, as well as meninges vascular bed

Trigeminal nerve is bipolar in nature:
• Dorsal horn spinal cord; pain
• Cranial blood vessel & meninges; vasodilation + inflammation (powerful mediator)

> > > Neurones contain CGRP (calcitonin gene related neuropeptide); potent vasodilator and plasma CGRP increases in migraine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the trigeminal nerve responsible for innervating?

A

Three divisions innervating the forehead and eye:

  • Ophthalmic V1 (goes up to meninges; most suspect)
  • Maxillary V2 (cheek)
  • Mandibular V3 (face and jaw)

These nerves:
• Sense facial touch, pain and temperature
• Control muscles used for chewing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is migraine diagnosed?

A
  • No definitive test/diagnosis
  • Careful assessment of patient history
  • Elimination of alternative causes of headache e.g. trauma, other drug treatments, rare disorders.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the diagnostic criteria for Common Migraine (without aura)?

A

International Classification of Headache Disorders, 2nd Edition (ICHD-II):

A:
- At least 5 attacks fulfilling criteria B-D (in one year)

B:
- Headache attacks lasting 4-72 hours
(untreated or unsuccessfully treated)

C:
Headache has AT LEAST 2 two of the following:
- Unilateral location
- Pulsating quality (i.e. varying with the heartbeat)
- Moderate or severe pain intensity
- Aggravation by or causing avoidance of routine physical activity (e.g. walking/climbing stairs)

D:
During headache, at least one of the following:
- Nausea and/or vomiting
- Photophobia and phonophobia

E:
Not attributed to another disorder:
- History and examination do not suggest a secondary headache disorder; or if they do, is ruled out by appropriate investigations or headache attacks do not occur for the first time in close temporal relation to the other disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How may migraine in children present differently to the Common/Classic Migraine?

A
  • Attacks may be shorter-lasting (not 4-72 hours)
  • Headache is more commonly bilateral
  • GI disturbance more prominent (often no N&V)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why are Migraine Diaries potentially helpful?

A
  • Help doctors make a firm diagnosis
  • Recognise warning signs of an attack
  • Identify triggers
  • Assessing whether acute or preventative medication is working
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What may Migraine Diaries include information on, that would be clinically helpful?

A
  • When the pain begins and frequency
  • Symptoms (e.g. nausea or vision aura)
  • Length of attacks
  • Pain location and whether throbbing, piercing

Extra:
• Diet, medication, vitamins/health products, exercise, sleep duration
• Women; menstrual cycle details

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some potential triggers/causes of migraine?

A

Avoid:

  • Mental stress (75%)
  • Refractory error in glasses
  • Chocolate, eggs, fruit (15%)
  • Alcohol
  • Oral contraceptives
  • Time zone shifts
  • Physical exertion (45%)
17
Q

What are the goals of pharmacological treatment for migraine?

A
  • Primary; provide acute relief to recurrent attacks

- Secondary; introduce effective prophylactic treatment

18
Q

Describe Step 1 of the Stepwise Approach for Mild and/or Occasional migraine attacks.

A

Step 1:

  • Acute (ASAP) treatment analgesics/NSAIDs = primary therapy
  • Anti-emetics useful if nausea troublesome
  • Most effective taken early during attack
  • Often self-medicate OTC
  • GP can add anti-emetic e.g. domperidone, metoclopramide, enhancing absorption as they accelerate gastric emptying
  • Combine with: rest and sleep
19
Q

Describe Step 2 of the Stepwise Approach for Mild and/or Occasional migraine attacks.

A

Step 2:

  • Triptans (Sumatriptan, Zolmitriptan etc.); mainstay of selective migraine (and cluster headache) therapy, but CV risks (not in IHD, hypertensive etc.)
  • Available OTC (18-65 y/o’s)
  • Short acting, poor CNS penetration (try nasal spray/buccal formulation)
  • May cause chest pain due to coronary artery vasoconstriction (thus CI in IHD)
  • Will not PREVENT aura; take during headache attack (separate mechanism)

> > > CGRP receptor antagonists in development e.g. Talcagepant; might be more effective w/lower CVS risk.

20
Q

What is the mechanism of action of the triptans?

A

Triptans (Sumatriptan, Zolmitriptan etc.):

  • 5-HT1B (on blood vessels) and 5-HT1D (on bipolar trigeminal nerve) agonists
  • Vasoconstriction of cranial blood vessels
  • Subsequent inhibition of CGRP neuropeptide release (attenuate vasodilation and pain)
21
Q

Describe Step 3 of the Stepwise Approach for MIgraine therapy.

A

Prophylactic therapy; in Severe Attacks and/or >2/month:

  • Avoid known patient-specific migraine triggers e.g. stress, dietary factors
  • β-blockers (propranolol, metoprolol), CCBs (flunarizine), anticonvulsants (valproate, topiramate; caution in pregnancy) OR pre-menstrual oestrogen can be effective.
  • Amitriptyline (TCA) also of value
  • CGRP receptor antagonists may be effective in future
22
Q

What is the NICE recommendation for prophylaxis of treatment-resistant migraine/frequent chronic migraine?

A

Treatment-resistant:

  • Acupuncture
  • Gabapentin

Frequent chronic migraine:
- Botulinum toxin type A

23
Q

What is Emesis?

A
  • Vomiting

- Protective reflex to expel ingested toxins, associated with nausea

24
Q

What is Nausea?

A
  • Unpleasant sensation that immediately precedes vomiting
  • Cold sweat, pallor, salivation, self-absorption, loss of gastric tone, duodenal contractions, and reflux of intestinal contents into stomach often accompany nausea.
25
Q

What is Vomiting?

A
  • Coordinated involuntary reflex involving powerful sustained contraction of the abdominal, chest wall and diaphragm muscles (which greatly increase intra-gastric pressure)
  • And opening of the cardioesophageal sphincter, glottis, jaws
  • Rapid evacuation of stomach contents up to and out of the mouth
  • Breathing is suspended; epiglottis closes over trachea at same time to avoid inhalation of vomit
  • Incomplete reflex where the sphincter does not open and nothing is ejected = retching; preliminary phase to vomiting.
26
Q

Describe the central control of emesis.

A
  • Generated and coordinated by vomiting centre; functionally related group of neurones in the medullary reticular formation (not a specific anatomical area)
  • Generates the motor components of the vomiting reflex, and receive inputs that trigger the reflex
27
Q

What are the main causes of N&V?

A
  • Iatrogenic (chemo, RT, opiates, antibiotics; from drugs)
  • Motion sickness and Meniere’s disease (middle ear disorder)
  • Pregnancy
  • Poisoning (e.g. ethanol; intoxication)
  • Gastroenteritis and stimulation of pharynx
  • Meningitis and intracranial haemorrhage (raised pressure)
  • Bulimia nervosa
28
Q

What are the inputs that feed the vomiting centre?

A

• CTZ (chemoreceptor zone); at base of the fourth ventricle, has multiple receptors (DA-2, 5-HT3, opioid, ACh M1); Substance P (a neurokinin) is the resulting major output transmitter

Other inputs:

  • Area postrema; detects blood chemicals e.g. toxins (has no BBB)
  • Vestibular system via vestibulocochlear (8th cranial) nerve; plays major role in motions sickness, rich in muscarinic cholinergic and H1 receptors
  • Vagal (10th cranial) nerve afferents, activated when pharynx is irritated, leading to gag reflex; nucleus tractus solitarius has high density of 5-HT3 and NK1 receptors
  • Vagal and other GI afferents; responding to irritation of GI mucosa by chemo, RT, distention or acute gastroenteritis via gut 5-HT3 receptors
  • Intracranial pressure receptors; mediate nausea after head injury or meningitis
  • Descending inputs; from higher centre (hypothalamus, cerebellum etc.) arising from sight or smell of vomit, situations associated w/vomiting, psychiatric disorders, or general stress
29
Q

When may it be necessary to actively induce vomiting?

A

Aid elimination of swallowed poisons:
- If poison is likely to still be in stomach
- If patient is not likely to inhale vomit; respiratory reflexes unimpaired
»> In these rare circumstances, vomiting induced by swallowing emetic ipecacuanha; directly activates CTZ.

30
Q

What drugs may be used to control nausea or vomiting?

A

May NTs provide input/output at vomiting centre:

  • 5-HT3 antagonists (ondansetron)
  • Corticosteroids (dexamethasone; eicosanoid synthesis inhibition)
  • NK1 antagonist (aprepitant; prevents Substance P binding)
  • DA D2 antagonists (metoclopramide, domperidone, haloperidol)
  • Anti-cholinergics (scopolamine)
  • Anti-histamine (cinnarizine)
  • Histamine H3 antagonists (betahistine; vertigo nausea)
  • Cannabinoid agonists (nabilone)
  • Multiple targets (DA, 5-HT, muscarinic antagonist; olanzapine)
31
Q

Where are the sites of action for various antiemetics?

A

P.283 diagram

  • BZDs; higher cortical centres
  • H1 antagonists; labyrinths (surgery)
  • NK1 antagonists; vomiting centre (general action)
  • Histamine/muscarinic/DA antagonists, cannabinoids; CTZ
  • 5-HT3 antagonists, sphincter modulators; stomach small intestine
32
Q

What is the most efficacious antiemetic in general?

A
  • Aprepitant; NK1 receptor antagonism

- As Substance P is the major output transmitter from the vomiting centre; thus active against most causes of vomiting

33
Q

What antiemetics are active against motion sickness?

A
  • H1 antagonists

- H3 antagonists

34
Q

How is CINV (chemotherapy induced N&V) controlled?

A

Combination of:
- Corticosteroid (dexamethasone)
- DA antagonist (metoclopramide)
- 5-HT3 antagonists (ondansetron)
»> Clinical trials shown that NK1 antagonist, 5-HT3 antagonist and a corticosteroid give 85-90% protection in highly emetic CINV
»> For less severe CINV, 5-HT3 antagonist and corticosteroid give 70-90% protection

35
Q

Why is nausea difficult to treat/control, even though it precedes vomiting? How is it tackled?

A
  • Due to interactions with higher centres
  • Partly a learned/associative response
  • Combination of anti-emetics and mild sedation (BZD) used to reduce severe nausea
36
Q

What are corticosteroids and 5-HT3 antagonists poor at controlling WRT N&V respectively?

A
  • Corticosteroids; not v. effective for acute vomiting

- 5-HT3 antagonists; not v. effective against non-CINV

37
Q

Why are some patients resistant to all anti-emetics?

A

Variant 5-HT receptors (proposed)